Temsirolimus, An mTOR Inhibitor, In Combination with Low-Dose Clofarabine in Older Patients with Advanced Acute Myeloid Leukemia: Results of a Phase 2 GIMEMA Study (AML-1107)
暂无分享，去创建一个
M. Vignetti | L. Pagano | G. Martinelli | G. Meloni | A. Martelli | D. Cilloni | V. Rizzoli | F. Pane | A. Venditti | S. Amadori | P. Fazi | F. Raimondo | C. Fozza | A. Piciocchi | L. Annino | M. Lunghi | E. Ammatuna | E. Sala